Skip to content

DrCastermansA

Active Private limited companyfounded 2022active for 4 yearsLange Lostraat 169, 3360 BierbeekKBO/BCE: BE 0789.224.365

Lifetime

4 annual accounts with figures on one time axis
peak of €186,707 in 2025
€186,707▲ 24.2%
peak of €142,120 in 2025
€142,120▲ 23.0%
peak of €202,589 in 2024
€5,000▼ 97.5%
€348,926▲ 92×
Board1 name since 2022
1 director
Documentsfilings and deeds
26-05-202666 days before the deadline
2025micro format
Gross margin from €150,352 to €186,707Dividend €339,709Equity from €202,589 to €5,000Debts from €3,787 to €348,926Cash from €144,154 to €76,221

Key points

from the 2025 annual accounts

Equity

€5,000 from €202,589 in 2024

Equity fell by 98% in 1 year.

Turnover

≈ €350,000 estimated

The micro format states no turnover.

Debts

€348,926 99% of the balance sheet
Suppliers 0%Taxes and wages 2%Other 97%

Liquidity

1.00 was 53.15 in 2024

Short-term debts rose from €3,787 to €348,926.

Filings

4 annual accounts since 2022
AprilJune31 JulyOctober2022202320242025

The last four annual accounts were filed 54 to 66 days before the end of the period.

Position in the sector

1.4%

Lower solvency than 94% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,155 companies had the same profile as DrCastermansA has now. Each dot stands for 6 companies, two years later.

94.1%
were still trading
2.8%
stopped another way
3.1%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,155 companies, not a prediction for DrCastermansA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 29-07-2022
  • founderdeed of 02-08-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0789224365
Registered office moved from Leuven to Bierbeek The registered office moved from Gemeentestraat 210, 3010 Leuven to Langelostraat 169, 3360 Bierbeek · Gazette deed
Incorporation Founding capital of €5,000, 100 shares · Founded by · appointed as director · published on 02-08-2022 · Gazette deed
First establishment Gemeentestraat 210, Leuven
All 11 events

Comparable companies

same main activity, similar in size and age
Company
DrCastermansA Bierbeek €353,926 €186,707 1.4% -
VDLELIE Beersel €377,220 €202,374 57.2% -
Dr. Toine Mercier Leuven €331,054 €205,186 67.7% -
IL OFTALMOLOGIE Wemmel €316,475 €185,150 92.4% -
MAMPAO Wemmel €396,033 €185,562 79.4% -
Dr Coremans Laura, gastro-enteroloog Asse €311,864 €185,790 72.3% -
GASTROMED Asse €334,161 €212,081 97.7% -

These companies have the same main activity as DrCastermansA: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €312,000 and €396,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 29-07-2022Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.333.837.7173010 Leuven, since 29-07-2022
Financial year end
31 December
Peppol
Reachable since 31-10-2025
Company details

Annual accounts 2025

€353,926▲ 71.5%
Filing
Filed on 26-05-2026, 66 days before the end of the filing period
Financials

Insights on DrCastermansA

DrCastermansA files the micro format. That format states no turnover. The gross margin rose from €4,668 in 2022 to €186,707 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DrCastermansA

What is the company number of DrCastermansA?
The company number of DrCastermansA is 0789.224.365. The VAT number is the same number with BE in front: BE 0789.224.365.
Where is DrCastermansA based?
The registered office is at Lange Lostraat 169, 3360 Bierbeek.Company details
What does DrCastermansA do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DrCastermansA?
DrCastermansA is a private limited company (BV).
When was DrCastermansA founded?
DrCastermansA was founded on 29-07-2022.
Is DrCastermansA still active?
Yes, DrCastermansA is an active enterprise in the KBO register.
What is the turnover of DrCastermansA?
The turnover in financial year 2025 is about €350,000. This figure is estimated from the gross margin of €186,707 and 40 comparable companies (NACE 86220). It probably lies between €290,000 and €460,000.Financials
Is DrCastermansA profitable?
In financial year 2025, DrCastermansA made a profit of €142,120.
Where can I find the annual accounts of DrCastermansA?
DrCastermansA filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DrCastermansA due?
DrCastermansA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.